Abstract
The aim of this study was to investigate hemocompatibility and cytotoxicity properties of synthetic polymer coatings containing various unsaturated carbonic acids with vinylacetate. Co-polymers of vinylacetate and crotonic acid (CA), maleic acid (MA), and itaconic acid (IA) were made. The materials were characterized in terms of their adhesion to metal supports (titanium and stainless steel) as well as hemocompatibility (% hemolysis, wettability, erythrocyte aggregation, hemoglobin content, thrombocyte count and lipid peroxidation levels) and cytotoxicity (human endothelial cell activity in vitro and chromosome aberrations, bone marrow proliferation and cell ploidy in rats). Co-polymers of unsaturated carbonic acids with vinylacetate exhibited good hemocompatibility properties, as opposed to vinylacetate homopolymer for which substantial levels of hemolysis were observed. By coating the metal supports with co-polymers the cytotoxic effects associated with the bare metal samples were markedly reduced. MA samples showed excellent hemocompatibility and no cytotoxicity, yet they lacked good adhesion properties to metal substrate, probably due to high water content. CA samples, having the highest density of carboxylic groups among the samples under investigation, showed increased bone marrow proliferation activity and cell ploidy in rats, as compared to controls. The most promising results in the present study were obtained for the samples with IA, which showed good adhesion to metal substrates, good hemocompatibility and low cytotoxicity. Thus, co-polymers of vinylacetate and IA rich in carboxylic groups are promising materials for the design of novel drug-eluting stents.
Similar content being viewed by others
References
Lau KW, Mak KH, Hung JS, Sigwart U. Clinical impact of stent construction and design in percutaneous coronary intervention. Am Heart J. 2004;147(5):764–73.
Lev EI, Assali AR, Teplisky I, Rechavia E, Hasdai D, Sela O, et al. Comparison of outcomes up to six months of heparin-coated with noncoated stents after percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol. 2004;93(6):741–3.
Lewis AL, Stratford PW. Phosphorylcholine-coated stents. J Long Term Eff Med Implants. 2002;12(4):231–50.
Ramsdale DR. Coronary artery stenting. Hosp Med. 1999;60(9):624–9.
Schuler G. Polymer-sirolimus-eluting stents in de novo lesions. Herz. 2004;29(2):152–61.
Sigwart U. Coronary stents. Z Kardiol. 1995;84:65–77.
Mani G, Feldman MD, Patel D, Agrawal CM. Coronary stents: a materials perspective. Biomaterials. 2007;28(9):1689–710.
Taylor A. Metals. In: Sigwart U, editor. Endoluminal stenting. London: W.B. Saunders Company Ltd; 1996. p. 28–33.
Haudrechy P, Foussereau J, Mantout B, Baroux B. Nickel release from 304 and 316 stainless-steels in synthetic sweat—comparison with nickel and nickel-plated metals—consequences on allergic contact dermatitis. Corros Sci. 1993;35(1–4):329–36.
Koster R, Vieluf D, Kiehn M, Sommerauer M, Kahler J, Baldus S, et al. Nickel and molybdenum contact allergies in patients with coronary in-stent restenosis. Lancet 2000;356(9245):1895–7.
Davis JR. Metallic materials. Materials Park, Ohio: ASM International; 2003.
Park JB, Kim YK. Metallic biomaterials. In: Park JB, Bronzio JD, editors. Biomat principles and applications. Boca Raton: CRC Press; 2003. p. 1–20.
Mueller PP, May T, Perz A, Hauser H, Peuster M. Control of smooth muscle cell proliferation by ferrous iron. Biomaterials. 2006;27(10):2193–200.
Peuster M, Hesse C, Schloo T, Fink C, Beerbaum P, von Schnakenburg C. Long-term biocompatibility of a corrodible peripheral iron stent in the porcine descending aorta. Biomaterials. 2006;27(28):4955–62.
Peuster M, Wohlsein P, Brugmann M, Ehlerding M, Seidler K, Fink C, et al. A novel approach to temporary stenting: degradable cardiovascular stents produced from corrodible metal-results 6–18 months after implantation into New Zealand white rabbits. Heart. 2001;86(5):563–9.
Gottsauner-Wolf M, Moliterno DJ, Lincoff AM, Topol EJ. Restenosis—an open file. Clin Cardiol. 1996;19(5):347–56.
Wijns W. Late stent thrombosis after drug-eluting stent: seeing is understanding. Circulation. 2009;120(5):364–5.
Bailey SR. DES design: theoretical advantages and disadvantages of stent strut materials, design, thickness, and surface characteristics. J Interv Cardiol. 2009;22(s1):s3–17.
Depalma VA, Baier RE, Gott VL, Ford JW, Furuse A. Investigation of 3-surface properties of several metals and their relation to blood compatibility. J Biomed Mater Res. 1972;6(4):37–75.
Dev V, Eigler N, Sheth S, Lambert T, Forrester J, Litvack F. Kinetics of drug delivery to the arterial wall via polyurethane-coated removable nitinol stent: comparative study of two drugs. Cathet Cardiovasc Diagn. 1995;34(3):272–8.
Lambert TL, Dev V, Rechavia E, Forrester JS, Litvack F, Eigler NL. Localized arterial wall drug delivery from a polymer-coated removable metallic stent. Kinetics, distribution, and bioactivity of forskolin. Circulation. 1994;90(2):1003–11.
Cooper SL, Visser SA, Hergenrother RW, Lamba NMK. Polymers. Biomaterials science an introduction to materials in medicine. San Diego: Elsevier Academic Press; 2004. p. 67–79.
Murphy JG, Schwartz RS, Edwards WD, Camrud AR, Vliestra RE, Holmer DR. Percutaneous polymeric stents in porcine coronary artery initial experience with polyethylene terephtalate stents. Circulation. 1992;86(5):1596–604.
Peng T, Gibula P, Yao KD, Goosen MF. Role of polymers in improving the results of stenting in coronary arteries. Biomaterials. 1996;17(7):685–94.
Tan LP, Venkatraman SS, Sung PF, Wang XT. Effect of plasticization on heparin release from biodegradable matrices. Int J Pharm. 2004;283(1–2):89–96.
Banai S, Gertz SD, Gavish L, Chorny M, Perez LS, Lazarovichi G, et al. Tyrphostin AGL-2043 eluting stent reduces neointima formation in porcine coronary arteries. Cardiovasc Res. 2004;64(1):165–71.
van der Giessen WJ, Lincoff AM, Schwartz RS, van Beusekom HM, Serruys PW, Holmes DR Jr, et al. Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation. 1996;94(7):1690–7.
Richard R, Schwarz M, Chan K, Teigen N, Boden M. Controlled delivery of paclitaxel from stent coatings using novel styrene maleic anhydride copolymer formulations. J Biomed Mater Res Part A. 2008;90A(2):522–32.
Edelman ER, Adams DH, Karnovsky MJ. Effect of controlled adventitial heparin delivery on smooth muscle cell proliferation following endothelial injury. Proc Natl Acad Sci USA. 1990;87(10):3773–7.
Final Report on the Safety Assessment of Vinyl Acetate/Crotonic Acid Copolymer. Int J Tox 1983;2(5):125–40.
Kabanov VY. Preparation of polymeric biomaterials with the aid of radiation-chemical methods. Russ Chem Rev. 1998;67:783–816.
Jozefowicz M, Jozefonvicz J. Antithrombogenic polymers. Pure Appl Chem. 1985;56(10):1335–44.
Lundell EO, Byck JS, Kwiatkowski GT, Osterholts FD, Creasy WS, Stewart DD. Biological and physical characterization of some polyelectrolytes. Polym Prepr Am Chem Soc, Div Polym Chem. 1975;16(2):541–4.
Shtilman MI. Polymeric biomaterials. Part I. Polymer implants. Utrecht-Boston: VSP Books; 2003.
Acknowledgements
International Science and Technology Center (ISTC) are gratefully acknowledged for financial support (grant A-1358 ISTC).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tavakalyan, N.B., Karapetyan, A.G., Pogosyan, A.S. et al. Influence of unsaturated carbonic acids on hemocompatibility and cytotoxicity of poly-vinylacetate based co-polymers. J Mater Sci: Mater Med 21, 1693–1702 (2010). https://doi.org/10.1007/s10856-010-4020-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10856-010-4020-x